The practice of drug emergency supply in China during the COVID-19 pandemic: A policy mix perspective.

ABSTRACT:

Background

Public health emergencies such as COVID-19 severely disrupt drug supply chains, creating sudden surges in demand, labor shortages, and regulatory challenges. Existing studies often focus on single supply chain stages, with limited systematic analysis of policy responses across the entire cycle.

Objectives

This study aims to systematically analyze China's emergency drug supply policies by examining issuing agencies, developmental stages, policy tools, and supply chain links, to identify patterns, complementarities, and existing gaps.

Methods

A total of 559 policy texts (110 national, 449 provincial) issued between December 2019 and February 2023 were collected. Content analysis and coding were conducted based on a four-dimensional framework. Social network a

SUBMITTER: Jie-Ying Z 

PROVIDER: S-EPMC12753071 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature